These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 80632)

  • 1. Subcutaneous ancrod in prevention of deep-vein thrombosis after operation for fractured neck of femur.
    Lowe GD; Campbell AF; Meek DR; Forbes CD; Prentice CR
    Lancet; 1978 Sep; 2(8092 Pt 1):698-700. PubMed ID: 80632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery.
    Belch JJ; Meek DR; Lowe GD; Campbell AF; Young AB; Forbes CD; Prentice CR
    Thromb Res; 1982 Jan 1-15; 25(1-2):23-31. PubMed ID: 7038977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous ancrod after operation for fractured hip--a dose-ranging and feasibility study.
    Lowe GD; Morrice JJ; Fulton A; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1978 Aug; 40(1):134-43. PubMed ID: 725844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femur.
    Barrie WW; Wood EH; Crumlish P; Forbes CD; Prentice CR
    Br Med J; 1974 Oct; 4(5937):130-3. PubMed ID: 4607845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of deep vein thrombosis by subcutaneous ancrod.
    Lowe GD
    Scott Med J; 1978 Oct; 23(4):329-30. PubMed ID: 364647
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous ancrod in prevention of deep-vein thrombosis.
    Lowe GD; Campbell AF; Meek DR; Forbes CD; Prentice CR
    Lancet; 1979 Jan; 1(8106):51-2. PubMed ID: 83504
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Chesterman CN; Williams EW; Faulkner T; Sharp AA
    Thromb Haemost; 1977 Apr; 37(2):222-32. PubMed ID: 577626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subcutaneous small heparin doses for the prevention of thrombosis in general surgery and urology].
    Rem J; Duckert F; Fridrich R; Gruber UF
    Schweiz Med Wochenschr; 1975 Jun; 105(26):827-35. PubMed ID: 1215880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.
    Lahnborg G
    Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery.
    Ascani A; Radicchia S; Parise P; Nenci GG; Agnelli G
    Thromb Haemost; 1996 Feb; 75(2):239-41. PubMed ID: 8815567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thrombosis after fractures of the upper end of the femur. A study of incidence and site.
    Culver D; Crawford JS; Gardiner JH; Wiley AM
    J Bone Joint Surg Br; 1970 Feb; 52(1):61-9. PubMed ID: 5436205
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
    Sagar S; Nairn D; Stamatakis JD; Maffei FH; Higgins AF; Thomas DP; Kakkar VV
    Lancet; 1976 May; 1(7970):1151-4. PubMed ID: 58199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin prophylaxis of deep vein thrombosis in patients with a fractured neck of the femur.
    Xabregas A; Gray L; Ham JM
    Med J Aust; 1978 Jun; 1(11):620-2. PubMed ID: 355810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rivaroxaban on preventing deep vein thrombosis in aged diabetics with femoral neck fractures after hip replacement.
    Zhang YM; Jiang X; Sun YS
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28442600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
    Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J
    J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small subcutaneous doses of heparin in prevention of venous thrombosis.
    Gallus AS; Hirsh J; Tutle RJ; Trebilcock R; O'Brien SE; Carroll JJ; Minden JH; Hudecki SM
    N Engl J Med; 1973 Mar; 288(11):545-51. PubMed ID: 4568221
    [No Abstract]   [Full Text] [Related]  

  • 19. Popliteal valve incompetence and postoperative deep vein thrombosis.
    Konradsen L; Jørgensen LN; Albrecht-Beste E; Nielsen SP
    Acta Chir Scand; 1990; 156(6-7):441-3. PubMed ID: 2195817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement.
    Fordyce MJ; Baker AS; Staddon GE
    BMJ; 1991 Jul; 303(6796):219-20. PubMed ID: 1884058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.